Massive transfusion policy in the Netherlands, a nationwide survey
Transfusion · 2025
DOI: 10.1111/trf.18243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von A M Van der Heiden und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Blood Transfusion. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Massive transfusion protocols (MTPs) guide the physician in optimizing transfusion strategies. Although international guidelines on massive transfusion exist, it is unknown whether all Dutch hospitals adhere to these guidelines. The main objective of this study was to create an overview of the massive transfusion strategies of Dutch hospitals and to evaluate if logistical factors, for example, the unavailability of thawed plasma, influence transfusion practices. Furthermore, this study was initiated to evaluate the interest in a ready‐to‐use plasma product. Study Design and Methods A questionnaire on transfusion strategy, available resources, and yearly usage/wastage of transfusion products was distributed to all hospitals in the Netherlands.
Results
Sixty‐nine hospitals were approached, of which 58 responded (response rate 84%). The majority of hospitals (67%) strived for a 1:1 erythrocyte/plasma ratio. Five percent of the hospitals used an erythrocyte/plasma ratio >2:1, which did not meet (inter)national guidelines. No relation was found between the clinical strategy described in the MTP and available resources; moreover, direct plasma availability did not increase plasma wastage. Hospitals for which it takes longer to have plasma available for transfusion generally are more interested in a ready‐to‐use plasma product ( n = 55, 75.0% vs. 57%).
Conclusion
This was the first nationwide survey on massive transfusion practices in the Netherlands. There is clear uniformity when it comes to using an MTP. Logistics surrounding plasma availability or plasma thawing capacity did not influence MTPs. Nevertheless, there seems to be substantial interest in a ready‐to‐use plasma product, especially in hospitals with limited plasma use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands.
- Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
- Military Blood Bank, Central Military Hospital, Utrecht, The Netherlands.
- Department of Transfusion Medicine, Sanquin Blood supply, Amsterdam, The Netherlands.
- Department of Product and Process Development, Sanquin Blood supply, Amsterdam, The Netherlands.
ORCID-Profile: M Ter Horst, F Noorman, N A Ottenhof
Zitieren
APA
Van der Heiden, A. M., Ter Horst, M., van Bohemen, M. R., Noorman, F., Novotny, V. M. J., Klei, T. R. L., & Ottenhof, N. A. (2025). Massive transfusion policy in the Netherlands, a nationwide survey. Transfusion. https://doi.org/10.1111/trf.18243
Vancouver
Van der Heiden AM, Ter Horst M, van Bohemen MR, Noorman F, Novotny VMJ, Klei TRL, et al. Massive transfusion policy in the Netherlands, a nationwide survey. Transfusion. 2025. doi:10.1111/trf.18243
BibTeX
@article{VanderHeiden2025,
author = {Van der Heiden, A M and Ter Horst, M and van Bohemen, M R and Noorman, F and Novotny, V M J and Klei, T R L and Ottenhof, N A},
title = {Massive transfusion policy in the Netherlands, a nationwide survey},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18243}
}
EUVIMED